These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Medical University of South Carolina Telestroke: A Telemedicine Facilitated Network for Stroke Treatment in South Carolina-A Progress Report. Al Kasab S; Adams RJ; Debenham E; Jones DJ; Holmstedt CA Telemed J E Health; 2017 Aug; 23(8):674-677. PubMed ID: 28170316 [TBL] [Abstract][Full Text] [Related]
3. Impact of telemedicine implementation in thrombolytic use for acute ischemic stroke: the University of Pittsburgh Medical Center telestroke network experience. Amorim E; Shih MM; Koehler SA; Massaro LL; Zaidi SF; Jumaa MA; Reddy VK; Hammer MD; Jovin TG; Wechsler LR J Stroke Cerebrovasc Dis; 2013 May; 22(4):527-31. PubMed ID: 23489955 [TBL] [Abstract][Full Text] [Related]
4. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry. Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276 [TBL] [Abstract][Full Text] [Related]
10. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience. Salam KA; Ummer K; Pradeep Kumar VG; Noone ML Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667 [TBL] [Abstract][Full Text] [Related]
11. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898 [TBL] [Abstract][Full Text] [Related]
12. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke. Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996 [TBL] [Abstract][Full Text] [Related]
13. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes. Williams JM; Navin TJ; Jude MR; Levi CR Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520 [TBL] [Abstract][Full Text] [Related]
17. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
18. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window. Li YH; Li MH; Zhao JG; Wang W J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996 [TBL] [Abstract][Full Text] [Related]
19. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments. Switzer JA; Hall C; Gross H; Waller J; Nichols FT; Wang S; Adams RJ; Hess DC J Emerg Med; 2009 Jan; 36(1):12-8. PubMed ID: 18242925 [TBL] [Abstract][Full Text] [Related]
20. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]